A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis

被引:60
作者
Suenobu, S
Takakura, N
Inada, T
Yamada, Y
Yuasa, H
Zhang, XQ
Sakano, S
Oike, Y
Suda, T [1 ]
机构
[1] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto, Japan
[2] Asahi Chem Ind Co Ltd, Cent Technol Lab, Res Dept 2, Shizuoka, Japan
关键词
D O I
10.1016/S0006-291X(02)00330-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Erythropoiesis is regulated not only by erythropoietin but also by microenvironments which are composed of transmembrane molecules. We have previously shown that a receptor tyrosine kinase EphB4 is predominantly expressed on human erythroid progenitors in bone marrow. EphB4 is expressed in approximately 45% of hematopoietic progenitor cells, which are CD34-positive and c-Kit-positive in human umbilical cord blood (hUCB). The transmembrane ligand for EphB4 or ephrin-B2 is expressed on bone marrow stromal cells and arterial endothelial cells. When such EphB4-positive hematopoietic progenitor cells were co-cultured with stromal cells which express ephrin-B2, they were immediately detached from stromal cells and differentiated to mature erythroid cells. At that time, expression of EphB4 immediately down-regulated. In contrast, on ephrin-B2 non-expressing stromal cells, they remained EphB4-positive cells and the generated number of mature erythroid cells was less than that on ephrin-B2 expressing stromal cells. Additionally, ephrin-B2 expression on endothelial cells up-regulated under hypoxic condition. Taken together, we propose that one of the molecular cues that regulate erythropoiesis is ephrin-B2 on stromal cells. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1124 / 1131
页数:8
相关论文
共 29 条
[21]  
LEARY AG, 1987, BLOOD, V70, P1343
[22]   Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization [J].
Murohara, T ;
Ikeda, H ;
Duan, J ;
Shintani, S ;
Sasaki, K ;
Eguchi, H ;
Onitsuka, I ;
Matsui, K ;
Imaizumi, T .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1527-1536
[23]  
PESCHLEC, 1977, BRIT J HAEMATOL, V37, P345
[24]  
Sakano S, 1996, ONCOGENE, V13, P813
[25]   Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization [J].
Shin, D ;
Garcia-Cardena, G ;
Hayashi, SI ;
Gerety, S ;
Asahara, T ;
Stavrakis, G ;
Isner, J ;
Folkman, J ;
Gimbrone, MA ;
Anderson, DJ .
DEVELOPMENTAL BIOLOGY, 2001, 230 (02) :139-150
[26]   Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis [J].
Takakura, N ;
Huang, XL ;
Naruse, T ;
Hamaguchi, I ;
Dumont, DJ ;
Yancopoulos, GD ;
Suda, T .
IMMUNITY, 1998, 9 (05) :677-686
[27]   EXPRESSION OF MAJOR BLOOD-GROUP ANTIGENS ON HUMAN ERYTHROID-CELLS IN A 2 PHASE LIQUID CULTURE SYSTEM [J].
WADA, H ;
SUDA, T ;
MIURA, Y ;
KAJII, E ;
IKEMOTO, S ;
YAWATA, Y .
BLOOD, 1990, 75 (02) :505-511
[28]   Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4 [J].
Wang, HU ;
Chen, ZF ;
Anderson, DJ .
CELL, 1998, 93 (05) :741-753
[29]  
Wood HB, 1997, BLOOD, V90, P2300